67 related articles for article (PubMed ID: 38578436)
21. Prognostic Implications of Preablation Stimulated Tg: A Retrospective Analysis of 2500 Thyroid Cancer Patients.
Tian T; Xu Y; Zhang X; Liu B
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4688-e4697. PubMed ID: 34143886
[TBL] [Abstract][Full Text] [Related]
22. The Value of Stimulated Thyroglobulin Before the First Radioactive Iodine Treatment in Metastasis for Differentiated Thyroid Carcinoma.
Ren L; Zhang C; Shen Y; Mo A; Hu Y; Sun J; Yuan C; Wen W
Clin Lab; 2021 Jun; 67(6):. PubMed ID: 34107643
[TBL] [Abstract][Full Text] [Related]
23. A cutoff thyroglobulin value suggestive of distant metastases in differentiated thyroid cancer patients.
Couto JS; Almeida MFO; Trindade VCG; Marone MMS; Scalissi NM; Cury AN; Ferraz C; Padovani RP
Braz J Med Biol Res; 2020; 53(11):e9781. PubMed ID: 33053096
[TBL] [Abstract][Full Text] [Related]
24. Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
Grani G; Zatelli MC; Alfò M; Montesano T; Torlontano M; Morelli S; Deandrea M; Antonelli A; Francese C; Ceresini G; Orlandi F; Maniglia CA; Bruno R; Monti S; Santaguida MG; Repaci A; Tallini G; Fugazzola L; Monzani F; Giubbini R; Rossetto R; Mian C; Crescenzi A; Tumino D; Pagano L; Pezzullo L; Lombardi CP; Arvat E; Petrone L; Castagna MG; Spiazzi G; Salvatore D; Meringolo D; Solaroli E; Monari F; Magri F; Triggiani V; Castello R; Piazza C; Rossi R; Ferraro Petrillo U; Filetti S; Durante C
Thyroid; 2021 Feb; 31(2):264-271. PubMed ID: 32475305
[No Abstract] [Full Text] [Related]
25. DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER.
Matrone A; Gambale C; Torregrossa L; Piaggi P; Bianchi F; Valerio L; Viola D; Agate L; Molinaro E; Materazzi G; Basolo F; Vitti P; Elisei R
Endocr Pract; 2020 Jan; 26(1):58-71. PubMed ID: 31557080
[No Abstract] [Full Text] [Related]
26. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
[No Abstract] [Full Text] [Related]
27. Radioiodine remnant ablation in papillary thyroid microcarcinoma: a meta-analysis.
Yang T; Zheng SY; Jiao J; Zou Q; Zhang Y
Nucl Med Commun; 2019 Jul; 40(7):711-719. PubMed ID: 31095043
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and therapeutic outcomes of patients with papillary thyroid microcarcinomas and larger tumors.
Zheng W; Wang X; Rui Z; Wang Y; Meng Z; Wang R
Nucl Med Commun; 2019 May; 40(5):477-483. PubMed ID: 30973839
[TBL] [Abstract][Full Text] [Related]
29. Stimulated Thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers.
Barres B; Kelly A; Kwiatkowski F; Batisse-Lignier M; Fouilhoux G; Aubert B; Dutheil F; Tauveron I; Cachin F; Maqdasy S
J Clin Endocrinol Metab; 2019 Aug; 104(8):3462-3472. PubMed ID: 30785995
[TBL] [Abstract][Full Text] [Related]
30. Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance.
Tuttle RM; Fagin JA; Minkowitz G; Wong RJ; Roman B; Patel S; Untch B; Ganly I; Shaha AR; Shah JP; Pace M; Li D; Bach A; Lin O; Whiting A; Ghossein R; Landa I; Sabra M; Boucai L; Fish S; Morris LGT
JAMA Otolaryngol Head Neck Surg; 2017 Oct; 143(10):1015-1020. PubMed ID: 28859191
[TBL] [Abstract][Full Text] [Related]
31. Practical Performance of the 2015 American Thyroid Association Guidelines for Predicting Tumor Recurrence in Patients with Papillary Thyroid Cancer in South Korea.
Lee SG; Lee WK; Lee HS; Moon J; Lee CR; Kang SW; Jeong JJ; Nam KH; Chung WY; Jo YS; Lee J
Thyroid; 2017 Feb; 27(2):174-181. PubMed ID: 27750028
[TBL] [Abstract][Full Text] [Related]
32. Systematic Review of Trends in the Incidence Rates of Thyroid Cancer.
Wiltshire JJ; Drake TM; Uttley L; Balasubramanian SP
Thyroid; 2016 Nov; 26(11):1541-1552. PubMed ID: 27571228
[TBL] [Abstract][Full Text] [Related]
33. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
34. Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation.
Mourão GF; Rosario PW; Calsolari MR
Endocr Relat Cancer; 2016 Jan; 23(1):47-52. PubMed ID: 26503963
[TBL] [Abstract][Full Text] [Related]
35. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Haugen BR; Alexander EK; Bible KC; Doherty GM; Mandel SJ; Nikiforov YE; Pacini F; Randolph GW; Sawka AM; Schlumberger M; Schuff KG; Sherman SI; Sosa JA; Steward DL; Tuttle RM; Wartofsky L
Thyroid; 2016 Jan; 26(1):1-133. PubMed ID: 26462967
[TBL] [Abstract][Full Text] [Related]
36. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis.
Sun W; Lan X; Zhang H; Dong W; Wang Z; He L; Zhang T; Liu S
PLoS One; 2015; 10(10):e0139021. PubMed ID: 26431346
[TBL] [Abstract][Full Text] [Related]
37. Stimulated Serum Thyroglobulin Level at the Time of First Dose of Radioactive Iodine Therapy Is the Most Predictive Factor for Therapeutic Failure in Patients With Papillary Thyroid Carcinoma.
Park HJ; Jeong GC; Kwon SY; Min JJ; Bom HS; Park KS; Cho SG; Kang SR; Kim J; Song HC; Chong A; Yoo SW
Nucl Med Mol Imaging; 2014 Dec; 48(4):255-61. PubMed ID: 26396629
[TBL] [Abstract][Full Text] [Related]
38. Total thyroidectomy versus lobectomy as initial operation for small unilateral papillary thyroid carcinoma: A meta-analysis.
Macedo FI; Mittal VK
Surg Oncol; 2015 Jun; 24(2):117-22. PubMed ID: 25956302
[TBL] [Abstract][Full Text] [Related]
39. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
[TBL] [Abstract][Full Text] [Related]
40. Low-risk differentiated thyroid cancer and radioiodine remnant ablation: a systematic review of the literature.
Lamartina L; Durante C; Filetti S; Cooper DS
J Clin Endocrinol Metab; 2015 May; 100(5):1748-61. PubMed ID: 25679996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
